SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 10/03/22 US Physical Therapy Inc./NV 8-K:7 10/03/22 11:657K |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 30K 2: EX-99.1 Miscellaneous Exhibit HTML 10K 6: R1 Document and Entity Information HTML 47K 9: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- form8-k_htm XML 15K 8: EXCEL IDEA Workbook of Financial Reports XLSX 8K 4: EX-101.LAB XBRL Labels -- usph-20221003_lab XML 63K 5: EX-101.PRE XBRL Presentations -- usph-20221003_pre XML 45K 3: EX-101.SCH XBRL Schema -- usph-20221003 XSD 14K 10: JSON XBRL Instance as JSON Data -- MetaLinks 13± 19K 11: ZIP XBRL Zipped Folder -- 0000885978-22-000049-xbrl Zip 17K
i Nevada
|
i 76-0364866
|
|||
(State or other jurisdiction
of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
i 1300 WEST SAM HOUSTON PARKWAY,
i SUITE 300,
i HOUSTON, i Texas
|
i 77043
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
i ☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
i ☐
|
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
|
i ☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
i ☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
i Common Stock, $.01 par value
|
i USPH
|
i New York Stock Exchange
|
Emerging growth company
|
i ☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
◻
|
Exhibits
|
Description of Exhibits
|
|
Registrant's Press Release dated October 3, 2022 *
|
U.S. PHYSICAL THERAPY, INC.
|
|||||||
Dated: October 3, 2022
|
By:
|
||||||
Chief Financial Officer
|
|||||||
(duly authorized officer and principal financial and accounting officer)
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 10/3/22 | None on these Dates | ||
List all Filings |